Please Wait...

IL-18 // Interleukin 18

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Interleukin 18 (IL-18) belongs to the IL-1 family and is produced by macrophages, dendritic cells and epithelial cells (keratinocytes). Pro-IL-18 is expressed constitutively and is then activated by caspase 1. Its receptor is IL-18R and the pro-inflammatory signaling requires the formation of a complex containing IL18, IL18R and IL-18RAP (Sims and Smith, 2010). In normal condition, IL-18 activity is lowered by high levels of IL-18 Binding Protein (IL-18BP). Binding of IL-18BP to IL-18 prevents its interaction with IL-18R. The ratio IL-18BP/IL-18 is altered in inflammatory conditions (Liang et al., 2006). Elevated levels of IL-18 have also been found to have a pertinent prognostic value in predicting cardiovascular mortality in patients with chronic kidney disease (Formanowicz et al., 2015).

Bioclinica Lab employs a manual sandwich immunoassay for the measurement of IL-18 in serum.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join Bioclinica in a live #Xtalks webinar 10/31 exploring challenges & benefits of different sourcing models to man… https://t.co/kRYNc1Z3gj
bioclinica (2 hours ago)
Bioclinica contributions toward advancement of #Alzheimer's disease research & therapies showcased in 8 different s… https://t.co/j96UN9568o
bioclinica (8 hours ago)
Bioclinica’s Joby John reflects on the #SCDM2018 Annual Conference & being a part a thriving community of clinical… https://t.co/c70gH5kJo9
bioclinica (Yesterday)
RT @bioclinica: Our own Jeff Heilbraun is in Tokyo nxt wk to lead a discussion at DIA’s Cardiac Safety Workshop in Japan. Jeff will give an…
bioclinica (Yesterday)
RT @Xtalks: Trends in #SitePayments: Insight into How CROs Can Gain a Competitive Edge This webinar will focus on the latest market researc…
bioclinica (Yesterday)
Great connecting w @bioclinica clients Odonate Therapeutics, Eisai, & PCI Biotech, at #ESMO18 #oncology… https://t.co/4wKrLof8e6
bioclinica (Yesterday)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner